Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Sawyer

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Antiviral Research|September 21, 2000
Antibodies for the prevention and treatment of viral diseasesL A Sawyer
AMHC Forum|October 8, 1981
A pastoral care assessment for the psychiatric team in the age of DSM - IIIL A Sawyer
Biologicals : Journal of the International Association of Biological Standardization|June 1, 1993
Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strainsL A Sawyer, J McInnis, P Albrecht
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1995
A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccinesD J Wood, A B Heath, L A Sawyer
Reviews of Infectious Diseases|September 1, 1987
Q fever: current conceptsL A Sawyer, D B Fishbein, J E McDade
Pharmaceutical Biotechnology|January 1, 1995
Clinical considerations in vaccine trials with special reference to candidate HIV vaccinesP E Fast, L A Sawyer, S L Wescott
American Journal of Diseases of Children (1960)|May 1, 1992
Antipyretic efficacy of ibuprofen vs acetaminophenR E Kauffman, L A Sawyer, M L Scheinbaum
AIDS (London, England)|June 1, 1988
Issues in the evaluation of AIDS vaccinesD A Katzenstein, L A Sawyer, G V Quinnan
The Journal of Infectious Diseases|August 1, 1988
Q fever in patients with hepatitis and pneumonia: results of laboratory-based surveillance in the United StatesL A Sawyer, D B Fishbein, J E McDade
Vaccine|July 1, 1994
Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccineL A Sawyer, J McInnis, A Patel, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Antiviral Research|September 21, 2000
Antibodies for the prevention and treatment of viral diseasesL A Sawyer
AMHC Forum|October 8, 1981
A pastoral care assessment for the psychiatric team in the age of DSM - IIIL A Sawyer
Biologicals : Journal of the International Association of Biological Standardization|June 1, 1993
Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strainsL A Sawyer, J McInnis, P Albrecht
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1995
A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccinesD J Wood, A B Heath, L A Sawyer
Reviews of Infectious Diseases|September 1, 1987
Q fever: current conceptsL A Sawyer, D B Fishbein, J E McDade
Pharmaceutical Biotechnology|January 1, 1995
Clinical considerations in vaccine trials with special reference to candidate HIV vaccinesP E Fast, L A Sawyer, S L Wescott
American Journal of Diseases of Children (1960)|May 1, 1992
Antipyretic efficacy of ibuprofen vs acetaminophenR E Kauffman, L A Sawyer, M L Scheinbaum
AIDS (London, England)|June 1, 1988
Issues in the evaluation of AIDS vaccinesD A Katzenstein, L A Sawyer, G V Quinnan
The Journal of Infectious Diseases|August 1, 1988
Q fever in patients with hepatitis and pneumonia: results of laboratory-based surveillance in the United StatesL A Sawyer, D B Fishbein, J E McDade
Vaccine|July 1, 1994
Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccineL A Sawyer, J McInnis, A Patel, et al.
Pageof 3